Life Sciences


Unmet Need Serotonergic psychedelics like psilocybin and LSD are known to possess considerable therapeutic potential. They exhibit impressive clinical promise for the treatment of inflammatory disease, substance use disorders, psychiatric disorders, and various neurological conditions. However, there are significant challenges, as these drugs are limited by their hallucinogenic effects, which requires close clinical supervision and […]

Despite all efforts to curb the epidemic of obesity through nutrition education, dieting, and exercise, current global efforts are failing as evidenced by the continuous rise in obesity levels, especially in developing countries.  Postprandial glycemia is directly associated with the development of diabetes and obesity. Further, the intake of refined carbohydrates, e.g., made from wheat […]

Unmet Need Targeted and long-lasting formulations of chemotherapeutics with low doses and few side effects. Opportunity Simple formulations to delivery two or more therapeutics to cancers with similar pharmacokinetic profiles. Easier to manufacture than nano / micro particles. Good to use in combination with immune checkpoint inhibitors. Unique Attributes Apoptotic agent that acts independently of […]

Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s disease, is a debilitating autoimmune condition that is clinically challenging to manage effectively. In the U.S., the CDC estimates that 1.3% of adults (about 3 million) have been diagnosed with IBD. Many IBD patients are diagnosed early in life. As a result of chronic […]